Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
4.300
+0.140 (3.37%)
Jan 2, 2025, 12:48 PM EST - Market open
Evotec SE Employees
Evotec SE had 5,061 employees as of December 31, 2023. The number of employees increased by 109 or 2.20% compared to the previous year.
Employees
5,061
Change (1Y)
109
Growth (1Y)
2.20%
Revenue / Employee
$171,244
Profits / Employee
-$37,766
Market Cap
1.51B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
EVO News
- 4 days ago - Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha
- 22 days ago - Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk - Accesswire
- 4 weeks ago - Evotec Announces Change in Management Board - Accesswire
- 5 weeks ago - Comment on Withdrawn Non-Binding Offer - Accesswire
- 5 weeks ago - Halozyme withdraws $2.1 bln buyout offer for Evotec - Reuters
- 5 weeks ago - Halozyme Withdraws Proposal to Acquire Evotec Following Evotec's Unwillingness to Engage in Discussions - PRNewsWire
- 6 weeks ago - Halozyme Provides Update on Non-Binding Proposal to Combine with Evotec - PRNewsWire
- 6 weeks ago - Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - Benzinga